Literature DB >> 8842034

Characterization of glucose dependent gel-sol phase transition of the polymeric glucose-concanavalin A hydrogel system.

A A Obaidat1, K Park.   

Abstract

PURPOSE: The main goal of this study was to synthesize and characterize hydrogels which undergo reversible gel-sol phase transformation in response to changes in glucose concentration in the surrounding environment.
METHODS: The glucose-sensitive hydrogels were made by mixing the appropriate concentrations of acrylamide-allyl glucose copolymer and concanavalin A (Con A). To examine their phase reversibility, hydrogels in dialysis membranes were cycled between glucose-free and glucose-containing buffers. The binding affinity of allyl glucose (AG) to Con A was examined by using an equilibrium dialysis technique.
RESULTS: The synthesized hydrogels underwent phase transition to sol in the presence of free glucose in the environment. The concentration of external free glucose (Cf) had to be at least 4 times that of polymer-bound glucose (Cp) to induce phase transition from gel to sol. The binding affinity study showed that binding of AG to Con A was four times stronger than that of free glucose. When Cp in the gel was 0.42 mg/ml or higher, Cf had to be much higher than 4 times Cp to induce phase transition.
CONCLUSIONS: The synthesized hydrogels underwent phase transition in the presence of free glucose in the environment, but the phase transition was not linearly dependent on the concentration of free glucose. This non-linear dependence was explained by the increased binding affinity of AG over native glucose to Con A, and the cooperative interactions between polymer-bound glucose and Con A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842034     DOI: 10.1023/a:1016090103979

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Kinetic parameters for the binding of p-nitrophenyl alpha-d-mannopyranoside to concanavalin A.

Authors:  S D Lewis; J A Shafer; I J Goldstein
Journal:  Arch Biochem Biophys       Date:  1976-02       Impact factor: 4.013

2.  Identification of Hemagglutinin of Jack Bean with Concanavalin A.

Authors:  J B Sumner; S F Howell
Journal:  J Bacteriol       Date:  1936-08       Impact factor: 3.490

3.  Studies on lectins. XXXI. Determination of dissociation constants of lectin. Sugar complexes by means of affinity electrophoresis.

Authors:  V Horejsí; M Tichá; J Kocourek
Journal:  Biochim Biophys Acta       Date:  1977-09-29

4.  Unusual fragments in the subunit structure of concanavalin A.

Authors:  J L Wang; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

5.  Protein-carbohydrate interaction. XX. On the number of combining sites on concanavalin A, the phytohemagglutinin of the jack bean.

Authors:  L L So; I J Goldstein
Journal:  Biochim Biophys Acta       Date:  1968-10-15

6.  External control of drug release: controlled release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic rats.

Authors:  S Miyazaki; C Yokouchi; M Takada
Journal:  J Pharm Pharmacol       Date:  1988-10       Impact factor: 3.765

7.  Magnetic modulation of release of macromolecules from polymers.

Authors:  D S Hsieh; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin.

Authors:  M Brownlee; A Cerami
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

9.  Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies.

Authors:  J Kost; T A Horbett; B D Ratner; M Singh
Journal:  J Biomed Mater Res       Date:  1985 Nov-Dec

10.  Kinetics of interaction of some alpha- and beta-D-monosaccharides with concanavalin A.

Authors:  R D Farina; R G Wilkins
Journal:  Biochim Biophys Acta       Date:  1980-09-01
View more
  14 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.

Authors:  Jinqiang Wang; Zejun Wang; Jicheng Yu; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Adv Mater       Date:  2019-08-18       Impact factor: 30.849

Review 3.  Biocompatibility issues of implantable drug delivery systems.

Authors:  H Park; K Park
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

4.  Glucose-binding property of pegylated concanavalin A.

Authors:  J J Kim; K Park
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

5.  Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

Authors:  Jinqiang Wang; Zejun Wang; Guojun Chen; Yanfang Wang; Tianyuan Ci; Hongjun Li; Xiangsheng Liu; Daojia Zhou; Anna R Kahkoska; Zhuxian Zhou; Huan Meng; John B Buse; Zhen Gu
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

Review 6.  Peptide-directed self-assembly of hydrogels.

Authors:  Jindrich Kopecek; Jiyuan Yang
Journal:  Acta Biomater       Date:  2008-10-14       Impact factor: 8.947

Review 7.  Hybrid multicomponent hydrogels for tissue engineering.

Authors:  Xinqiao Jia; Kristi L Kiick
Journal:  Macromol Biosci       Date:  2009-02-11       Impact factor: 4.979

Review 8.  Smart approaches to glucose-responsive drug delivery.

Authors:  Matthew J Webber; Daniel G Anderson
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

9.  HYDROGELS FROM SOFT CONTACT LENSES AND IMPLANTS TO SELF-ASSEMBLED NANOMATERIALS.

Authors:  Jindřich Kopeček
Journal:  J Polym Sci A Polym Chem       Date:  2009-11-15       Impact factor: 2.702

10.  Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.

Authors:  Efstathios Karathanasis; Rohan Bhavane; Ananth V Annapragada
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.